MIP
WST icon

Marietta Investment Partners’s West Pharmaceutical WST Stock Holding History

Marietta Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-818
Closed -$247K – 182
2022
Q2 		$247K Sell
818
-14,456
-95% -$4.7M 0.07% 154
2022
Q1 		$6.27M Buy
15,274
+109
+0.7% +$42.7K 1.43% 21
2021
Q4 		$7.11M Buy
15,165
+426
+3% +$183K 1.5% 18
2021
Q3 		$6.26M Buy
+14,739
New +$6.21M 1.43% 18

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marietta Investment Partners's WST Position: Q3 2022 in Review

Marietta Investment Partners sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 818 shares — an estimated $247K sold.

Marietta Investment Partners first reported a position in WST in Q3 2021 and held it in 4 quarters. The position peaked at $7.11M in Q4 2021. 639 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Marietta Investment Partners reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Marietta Investment Partners sold 818 West Pharmaceutical shares in Q3 2022, an estimated $247K.
  • Marietta Investment Partners first reported a position in West Pharmaceutical in Q3 2021 and held it in 4 quarters.
  • Marietta Investment Partners's West Pharmaceutical position peaked at $7.11M in Q4 2021.
  • 639 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Marietta Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.